Evidence map›Paper›PMID 28765526›Full record

ArticleScientific reports2017

CDHR1 mutations in retinal dystrophies.

Katarina Stingl, Anja K Mayer, Pablo Llavona, Lejla Mulahasanovic, Günther Rudolph, Samuel G Jacobson, Eberhart Zrenner, Susanne Kohl, Bernd Wissinger, Nicole Weisschuh

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Genes · 2026
    Article
  5. Article
  6. Article
  7. Posterior segment findings in a patient with aAmerican journal of ophthalmology case reports · 2024
    Article
  8. Rescue of cone and rod photoreceptor function in a CDHR1-model of age-related retinal degeneration.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  9. Article
  10. Article
  11. Medicina (Kaunas, Lithuania) · 2023
    Article
  12. Article
  13. Article
  14. Choroideremia Carriers: Dark-Adapted Perimetry and Retinal Structures.Investigative ophthalmology & visual science · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Novel mutations inInternational journal of ophthalmology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Katarina StinglInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Anja K MayerInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Pablo LlavonaInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Lejla MulahasanovicCeGaT GmbH and Praxis fuer Humangenetik Tuebingen, Tuebingen, Germany.
Günther RudolphUniversity Eye Hospital, Ludwig Maximilians University, Munich, Germany.
Samuel G JacobsonScheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Eberhart ZrennerInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Susanne KohlInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany.ORCID 0000-0002-6438-6331
Bernd WissingerInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Nicole WeisschuhInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany. nicole.weisschuh@uni-tuebingen.de.
STZ eyetrial · DELudwig-Maximilians-Universität München · DEPenn Presbyterian Medical Center · USPraxis für Humangenetik Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report ophthalmic and genetic findings in patients with autosomal recessive retinitis pigmentosa (RP), cone-rod dystrophy (CRD) or cone dystrophy (CD) harboring potential pathogenic variants in the CDHR1 gene. Detailed ophthalmic examination was performed in seven sporadic and six familial subjects. Mutation screening was done using a customized next generation sequencing panel targeting 105 genes implicated in inherited retinal disorders. In one family, homozygosity mapping with subsequent candidate gene analysis was performed. Stringent filtering for rare and potentially disease causing variants following a model of autosomal recessive inheritance led to the identification of eleven different CDHR1 variants in nine index cases. All variants were novel at the time of their identification. In silico analyses confirmed their pathogenic potential. Minigene assays were performed for two non-canonical splice site variants and revealed missplicing for the mutant alleles. Mutations in CDHR1 are a rare cause of retinal dystrophy. Our study further expands the mutational spectrum of this gene and the associated clinical presentation.

Indexed as

MutationCadherin Related ProteinsCadherinsCone-Rod DystrophiesGenetic Association StudiesHigh-Throughput Nucleotide SequencingHumansNerve Tissue ProteinsRetinitis PigmentosaCadherin Related ProteinsCadherinsCDHR1 protein, humanNerve Tissue Proteins

Identifiers

PMID28765526
PMCPMC5539332
OpenAlexW2737634175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.